Here's what happens next if an F.D.A. panel recommends pediatric Covid shots.
An independent committee of experts advising the Food and Drug Administration is meeting on Tuesday for discussion whether to recommend authorizing the Pfizer-BioNTech coronavirus vaccine for children 5 to 11 years old, which could open the way to inoculating 28 million children in the United States.